Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Dec. 3, 2010

View Archived Issues

Abiomed hopes to tap into STEMI market with study

Report from Europe: St. Jude receives CE mark, TGA approval for Penta lead

Washington roundup: CMS proposes trial coverage of MRI with ICDs, pacemakers

Deals roundup: Hanger Ortho completes ACP buy for nearly $155M

MDD's food for med-tech thought

Med-Tech Notes

Financings roundup: Sequenom seeks $84M via offering of 14M shares

RSNA notebook: Panel addresses safety in medical imaging use

People in the News

Product Briefs

Medtronic Spine's Horizon cleared for AIS treatment

MDD's Diagnostics Extra

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...